In order to investigate the relationship between MDH2 regulation of ccRCC proliferation and programmed cell death, we used various programmed cell death inhibitors to intervene in MDH2-OE and NC cell lines. Here, MDH2 is linked to nonpapillary renal cell carcinoma.